<DOC>
	<DOCNO>NCT00704769</DOCNO>
	<brief_summary>Evaluate safety general clinical response desloratadine syrup relief symptom associate perennial allergic rhinitis Indonesian pediatric patient .</brief_summary>
	<brief_title>Response Desloratadine Syrup Relief Symptoms Associated With Perennial Allergic Rhinitis Pediatric Patients ( Study P04299 )</brief_title>
	<detailed_description>Children , age 2-11 , history perennial allergic rhinitis</detailed_description>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Perennial</mesh_term>
	<mesh_term>Desloratadine</mesh_term>
	<criteria>Children patient sex age 211 year , either gender race Unequivocal history perennial allergic rhinitis , include nasal congestion , sneeze , rhinorrhea , pruritus , lacrimation Minimum score inclusion : 10 Capable comply dose regimen Free clinically significant disease ( allergic rhinitis ) Antihistamine must justify investigate doctor Patients asthma require chronic use inhale systemic corticosteroid History frequent , clinically significant sinusitis chronic purulent postnasal drip Patients rhinitis medicamentosa History hypersensitivity desloratadine excipients Doctor deem unsuitable</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>11 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>